To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Efficiently producing fatty acids and biofuels from glucose
- Bayer: Third quarter below prior year as expected - Group outlook confirmed - By the end of next year, Bayer will remove multiple layers of management and coordination
- Galactose-1-phosphate_uridylyltransferase_galactosemia
- Roche: Phase III study evaluating ocrelizumab in patients with rheumatoid arthritis meets primary endpoint
